The DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
SOCS3, a Major Regulator of Infection and Inflammation
Open accessAbstract
In this review, we describe the role of suppressor of cytokine signaling-3 (SOCS3) in modulating the outcome of infections and autoimmune diseases as well as the underlying mechanisms. SOCS3 regulates cytokine or hormone signaling usually preventing, but in some cases aggravating, a variety of diseases. A main role of SOCS3 results from its binding to both the JAK kinase and the cytokine receptor, which results in the inhibition of STAT3 activation. Available data also indicate that SOCS3 can regulate signaling via other STATs than STAT3 and also controls cellular pathways unrelated to STAT activation. SOCS3 might either act directly by hampering JAK activation or by mediating the ubiquitination and subsequent proteasome degradation of the cytokine/growth factor/hormone receptor. Inflammation and infection stimulate SOCS3 expression in different myeloid and lymphoid cell populations as well as in diverse non-hematopoietic cells. The accumulated data suggest a relevant program coordinated by SOCS3 in different cell populations, devoted to the control of immune homeostasis in physiological and pathological conditions such as infection and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC5 promotes the upregulation of Chemokine ligand 2 (CCL2) by inhibiting SOCS3, thereby recruiting CCR2+ macrophages [147].”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.013 · Cited by 96
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Binding to the cytokine activates the kinase function of JAK, a tyrosine kinase that binds to the receptor, which auto-phosphorylates itself, cross-phosphorylates a JAK molecule bound to the accompanying heterodimer chain of the cytokine receptor and also different tyrosine sites on the cytokine receptor (1).”
BackgroundNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 4×
“SOCS3 has been also suggested to inhibit IL-12-induced STAT4 activation by direct binding to IL-12Rβ2 (37), the IL-12R subunit that is not shared with the IL-23R.”
BackgroundInfluentialJournal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,427
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Flagged first, then by citations
1 of the 179 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 566
Yu, T., Yan, J., Wang, R., Zhang, L., Hu, X., Xu, J., Li, F., & Sun, Q. (2024) · Antioxidants · doi:10.3390/antiox13020214 · Cited by 9
“Therefore, SOCS1 has crucial implications for maintaining immune homeostasis, especially under pathological conditions like autoimmunity [50].”
BackgroundPlasma Circular RNAs as Biomarkers for Breast Cancer
Tierno, D., Grassi, G., Zanconati, F., Dapas, B., & Scaggiante, B. (2024) · Biomedicines · doi:10.3390/biomedicines12040875 · Cited by 10
“Zhiyang Li et al. indicated that hsa_circ_0001785 inhibits cell proliferation and invasion in BC cell lines (T47D, and MDA-MB-231) through miR-942 sponging and subsequent upregulation of SOCS3 [61], an oncosuppressor involved in cytokine signaling [62].”
BackgroundZeng, L., Wang, Y., Shen, J., Wei, X., Wu, Y., Chi, X., Zheng, X., Yu, X., Shi, Y., & Liu, W. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114287 · Cited by 9
Du, J., Jiang, H., & Bing, W. (2022) · Biochemical Genetics · doi:10.1007/s10528-021-10179-z · Cited by 10
“Suppressor of cytokine signaling 3 (SOCS3) has been proved to regulate inflammatory factors (Carow and Rottenberg 2014) and SOCS3 can regulate IL-6 signaling (Croker et al.”
BackgroundDinarello, A., Mills, T., Tengesdal, I. W., Powers, N. E., Azam, T., & Dinarello, C. A. (2023) · Cells · doi:10.3390/cells12020294 · Cited by 9
“Socs3 encodes for an inhibitor of STAT3 that belongs to the negative feedback loop of JAK/STAT3 axis, and is the first transcript to be induced when STAT3 is active [65].”
BackgroundDevalraju, K. P., Neela, V. S. K., Chintala, S., Krovvidi, S. S., & Valluri, V. L. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0164 · Cited by 9
SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development
Gao, Y., Liu, R., He, C., Basile, J. I., Vesterlund, M., Wahren‐Herlenius, M., Espinoza, A., Hokka-Zakrisson, C., Zadjali, F., Yoshimura, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642173 · Cited by 9
“SOCS proteins act as substrate adapters for ubiquitination and proteosomal degradation of different receptors (11).”
BackgroundSelf-citationLaubach, K., Yan, W., Kong, X., Sun, W., Chen, M., Zhang, J., & Chen, X. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123202119 · Cited by 9
Xie, K., Zeng, J., Wen, L., Peng, X., Lin, Z., Xian, G., Guo, Y., Yang, X., Li, P., Xu, D., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.11.017 · Cited by 10
Mechanism of herpesvirus protein kinase UL13 in immune escape and viral replication
Zhou, L., Cheng, A., Wang, M., Wu, Y., Yang, Q., Tian, B., Ou, X., Sun, D., Zhang, S., Mao, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1088690 · Cited by 9
Relationship of SOCS3 and TGF-β with IDO expression in early pregnancy chorionic villi and decidua
Liu, W., Huang, Y., Huang, G., Congrong, Z., Zeng, X., Zhao, S., Wu, L., Zhou, H., Wu, Q., & Dai, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5142 · Cited by 9
“The expression of SOCS3 is decreased in the placentas of women with intrahepatic cholestasis, demonstrating its essential role in placental development (2,3).”
Tong, G., von Garlen, N. N. A., Wowro, S. J., Lam, P. D., Krech, J., Berger, F. F., & Schmitt, K. R. L. (2019) · Mediators of Inflammation · doi:10.1155/2019/6431957 · Cited by 9
“Unlike necrosis, apoptosis can have beneficial effects and be reversed by the activation of prosurvival pathways, including the Janus kinase- (JAK-) STAT signaling pathway in which cardiacspecific SOCS-3 plays a key role in promoting myocardial IR-induced injury [21].”
BackgroundGhosh, R. B., & Bishayi, B. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106518 · Cited by 8
Huang, Z., Wang, H., Wang, D., Zhao, X., Liu, W., Zhong, X., He, D., Mu, B., & Lu, M. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17593 · Cited by 7
Wang, X.-Z., Wen, L., Zhou, Y., Huang, S., Yang, B., Cheng, S., Zeng, W., Mei, M., Sun, J., Jiang, X. J., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011166 · Cited by 9
“SOCS3 has been extensively investigated in immune cells for its role in regulating inflammation [19].”
BackgroundMicroRNAs Regulate Tumorigenesis by Downregulating SOCS3 Expression: An In silico Approach
Al-Asadi, S. A., Mansour, H., Ataimish, A. H., Al-Kahachi, R. E. S., & Rampurawala, J. (2023) · Bioinformatics and Biology Insights · doi:10.1177/11779322231193535 · Cited by 8
Lindenkamp, C., Plümers, R., Osterhage, M. R., Vanakker, O. M., Wynsberghe, J. V., Knabbe, C., & Hendig, D. (2023) · Biomedicines · doi:10.3390/biomedicines11102673 · Cited by 8
“Furthermore, we showed an increased gene expression of SOCS3, a negative regulator of JAK/STAT3 signaling in PXEF [23], which inhibits the activity of JAK and, consequently, the activation and phosphorylation of STAT3 [42].”
BackgroundTylek, K., Trojan, E., Leśkiewicz, M., Francavilla, F., Lacivita, E., Leopoldo, M., & Basta‐Kaim, A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00525 · Cited by 8
Liu, J., Cao, S., Liu, M., Chen, L., & Zhang, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-23926-x · Cited by 8
Yamawaki, Y., Shirawachi, S., Mizokami, A., Nozaki, K., Ito, H., Asano, S., Oue, K., Aizawa, H., Yamawaki, S., Hirata, M., et al. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104563 · Cited by 7
Liang, E. Y., Li, X., Fu, W., Zhao, C., Yang, B., & Yang, Z. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s298966 · Cited by 8
Cavin-1 promotes M2 macrophages/microglia polarization via SOCS3
Huang, W., Hong, Y., He, W., Jiang, L., Deng, W., Peng, B., Tang, F., Shen, C., Lan, Q., Huang, H., et al. (2022) · Inflammation Research · doi:10.1007/s00011-022-01550-w · Cited by 9
“Some studies have shown that the inhibition of SOCS3 can limit the function of inflammatory cytokines and affect the polarization of macrophages [29, 30].”
BackgroundInsights into gene expression profiles induced by Socs3 depletion in keratinocytes
Bajpai, A., Ishii, T., Miyauchi, K., Gupta, V., Nishio-Masaike, Y., Shimizu‐Yoshida, Y., Kubo, M., & Kitano, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-16155-1 · Cited by 8
Azeez, O. I., Myburgh, J. G., Bosman, A.-M., Featherston, J., Sibeko-Matjila, K. P., Oosthuizen, M. C., & Chamunorwa, J. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225073 · Cited by 8
“These SOCS proteins negatively regulate the signaling pathway of hormones including leptin and insulin [71, 72].”
BackgroundMasood, K. I., Irfan, M., Masood, Q., Yameen, M., Jamil, B., Ram, N., Rao, S., Rottenberg, M. E., & Hasan, Z. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13134 · Cited by 9
Self-citationMolecular Network of NLRP3 Inflammasome Activation- Responsive Genes in a Human Monocyte Cell Line
Kawana, N., Yamamoto, Y., Kino, Y., & Satoh, J. (2014) · Cited by 8
Zhao, J., Jaffe, A., Li, H., Lindenbaum, O., Sefik, E., Jackson, R. P., Cheng, X., Flavell, R. A., & Kluger, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/711929 · Cited by 8
Rosa, T. L. S. A., Leal-Calvo, T., Tavares, I. F., Mendes, M. A., Dias, A. A., Piauy, M. H. D. S., Barboza, M. F. D. S., Kapuscinski, M. L., Costa, F. D. M. R., Marques, M. A. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1366125 · Cited by 7
“…the level in LL (log 2 FC = 2.96, adj. p = 0.0003), followed by SOCS3 (log 2 FC = 2.05, adj. p = 0.001), a master regulator of the immune response (42), and FCGR1A (log 2 FC = 1.97, adj. p = 0.003) and FCGR1B (log 2 FC = 1.90, adj. p = 0.003), encoding the Fc gamma receptors 1A (CD64A) and 1B…”
BackgroundInfluentialLiang, T., Zhang, Z., Bai, Z., Xu, L., & Xu, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169007 · Cited by 7
Rowe, T., Fletcher, A., Svoboda, P., Pohl, J., Hatta, Y., Jasso, G., Wentworth, D. E., & Ross, T. M. (2024) · npj Vaccines · doi:10.1038/s41541-024-00973-2 · Cited by 7
“In the URT, SOCS3 was upregulated in all ferrets and has been shown to down-modulate IFN signaling in a RIG-I-dependent pathway to inhibit antiviral responses and suppress the in fl ammatory response 54 – 56 .”
Huse, C., Murphy, S. L., Yang, K., Balzer, N. R., Stokke, M. K., Anstensrud, A. K., Bjerkeli, V., Rentz, T., Jha, P. K., Ugland, H. K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105960 · Cited by 9
NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer
Tang, Y., Deng, X., Wang, Y., Zhou, Q., Zhang, C., Liu, Z., Zheng, R., Zeng, J., Tan, X., Wu, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08306-4 · Cited by 9
Stat3 role in the protective effect of FXR Agonist in parenteral nutrition-associated cholestasis
Ghosh, S., Devereaux, M. W., Anderson, A. L., Kasmi, K. C. E., & Sokol, R. J. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000056 · Cited by 8
“[6] As accumulation of phytosterols (PS) in the liver (from the i.v. lipid emulsion) during PNAC interferes with FXR signaling and bile-transporter expression,[23] we next examined the interaction between PS, STAT3, and FXR signaling. siRNA knockdown of STAT3 in HepG2 or Huh7 cells significantly reduced STAT3 mRNA lev…”
MethodInfluentialWu, H., Yang, L., Yuan, J., Zhang, L., Tao, Q., Yin, L., Xia, Y., & Lin, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1435135 · Cited by 7
“Through this mechanism, SOCS3 participates in controlling various cellular functions, including cell growth, differentiation, migration, and inflammatory responses (45, 46).”
BackgroundSun, K., Wu, F., Zheng, J., Wang, H., Li, H., & Xie, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136961 · Cited by 7
RetractedZhang, P., Pei, B., Yi, C., Akanyibah, F. A., & Mao, F. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167578 · Cited by 7
Snapshots of nascent RNA reveal cell- and stimulus-specific responses to acute kidney injury
Shen, T. H., Stauber, J., Xu, K. H., Jacunski, A., Paragas, N., Callahan, M., Banlengchit, R., Levitman, A. D., de Oliveira, B. D., Beenken, A., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146374 · Cited by 7
Lin, Z.-L., Liu, Y., Gao, Y., Chen, X.-S., Wang, C., Shou, S., & Chai, Y. (2022) · Genes & Genetic Systems · doi:10.1266/ggs.21-00073 · Cited by 7
STAT-3 signaling role in an experimental model of nephropathy induced by doxorubicin
Santos, T. C. D. O., Pereira, G., Coutinho, A. G. G., Silva, H. P. D. S., Lima, M. M. S., Dias, F. A. L., de Almeida, D. C., Silva, D. T. D. R. E., Perez, R. F., & Pereira, R. L. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04574-2 · Cited by 7
Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo
Fetisov, T. I., Анатольевна, Б. А., Antipova, A. S., Antoshina, E. E., Trukhanova, L. S., Gorkova, T., Zuevskaya, S. N., Maslov, A. A., Gurova, K. V., Gudkov, A. V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11010230 · Cited by 7
“4 * * SOCS3 PPARγ target gene, negative regulator via JAK/STAT [80] −2.”
Hang, D., Yin, Y., Wang, L., Yuan, H., Du, J., Zhu, M., Dai, J., Chen, N., Hu, Z., Shen, H., et al. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12539 · Cited by 7
Kuang, D., Dong, L., Liu, L., Zuo, M., Xie, Y., Li, T., & Yang, Z. (2021) · BioMed Research International · doi:10.1155/2021/8445461 · Cited by 7
“And it has been shown to be involved in regulating signal transduction through a variety of cytokines, including insulin signaling and leptin signaling Carow & Rottenberg [7].”
BackgroundRetractedKels, M. J. T., Ng, E., Rumaih, Z. A., Pandey, P., Ruuls, S. R., Körner, H., Newsome, T. P., Chaudhri, G., & Karupiah, G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.22.883728 · Cited by 7
“It is likely that the combined actions of increased levels of PIAS3 and SOCS3 in the anti-IL-6-treated mice contributed to dampening of STAT3 activation and to effective amelioration of lung pathology and survival of mice.”
BackgroundInfluentialFilgotinib Improves Experimental Pulmonary Fibrosis by Modulating JAK1/STAT3/SOCS3/IL‐17A Signalling
Lv, Y., Zhang, G., Kong, D., & Jiang, W. (2025) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.70012 · Cited by 6
Schmitz, L., Opsasnick, L. A., Ratliff, S. M., Faul, J. D., Zhao, W., Hughes, T. M., Ding, J., Liu, Y., & Smith, J. A. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf121 · Cited by 7
“Both inflammation and infection can stimulate the expression of SOCS3 in different cell populations (72). cg18181703 was also identified in prior EWAS of educational attainment and social disadvantage (4, 73).”
Zuo, X., Kuang, X., Zhao, Y., Tuo, J., Bai, H., Zhao, Q., Zhao, X. J., & Feng, X. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05186-9 · Cited by 6
“Socs3 binds to JAK kinase to inhibit further Stat3 activation, thereby maintaining signaling balance [81].”
Bu, Y., Chen, D., Li, J., Yang, R., Gao, J. L., Qu, W., Fu, X., Liu, W., Ding, Z., Zhou, J., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218066 · Cited by 6
Jeong, J., Lee, J. W., Talaia, G., Kim, W., Song, J., Hong, J., Yoo, K., Gonzalez, D. G., Athonvarangkul, D., Shin, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05044-8 · Cited by 6
Nie, M., Li, X., Zhang, S., Zeng, D., Cai, Y., Peng, D., Jiang, T., Shi, J.-P., & Li, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1431979 · Cited by 6
“Analysis of the expression changes of genes in key signaling pathway indicated that it could upregulate the expression of certain genes related to immunity, such as IRF3 (Al and Brady, 2022), SOCS3 (Carow and Rottenberg, 2014), and IL32 (Zhu et al., 2022) (Figure 5C).”
BackgroundRist, M., Kaku, M., & Coffin, J. M. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013087 · Cited by 6
“Additionally, downstream targets of STAT3, such as SOCS3 [59,60] and SGK1 [61], were also upregulated (Fig 3D).”
Socs3 ablation in kisspeptin cells partially prevents lipopolysaccharide-induced body weight loss
Bohlen, T. M., de Paula, D. G., Teixeira, P. D. S., Mansano, N. D. S., Alves, G. A., Donato, J., & Frazão, R. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155999 · Cited by 6
Singh, J., Sangwan, N., Chauhan, A., & Avti, P. (2022) · Clinical Breast Cancer · doi:10.1016/j.clbc.2022.09.002 · Cited by 6
Wanelik, K. M., Begon, M. E., Bradley, J. E., Friberg, I. M., Jackson, J. A., Taylor, C. H., & Paterson, S. (2022) · eLife · doi:10.7554/elife.77666 · Cited by 6
“151 Both Il33 and Socs3 also share an association with the inflammatory response [26,27].”
BackgroundMillar, B., & de Gaetano, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125858 · Cited by 7
“SOCS3 inhibits macrophage-mediated Th1 activation and the subsequent release of pro-inflammatory cytokines IL-1, IL-6, TNF-α, and MMPs (Carow and Rottenberg, 2014).”
BackgroundInfluentialQueen, N. J., Huang, W., Zou, X., Mo, X. M., & Cao, L. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.09.004 · Cited by 7
Morgan, R. C., Frank, C., Greger, M., Attaway, M., Sigvardsson, M., Bartom, E. T., & Kee, B. L. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200809 · Cited by 6
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
Al-Musa, A., LaBere, B., Habiballah, S. B., Nguyen, A. A., & Chou, J. S. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.12.775 · Cited by 6
“It inhibits antigen presentation and proinflammatory cytokine secretion from monocytes and dendritic cells by reducing MHC class II expression and restrains T-cell activation,(87,88) in part through upregulating expression of the suppressor of cytokine signaling protein 3, which inhibits CD8(1) T-cell proliferation.(8…”
BackgroundFetal anemia and elevated hepcidin in a mouse model of fetal alcohol spectrum disorder
Helfrich, K. K., Saini, N., Kwan, S. T., Rivera, O. C., Mooney, S. M., & Smith, S. M. (2023) · Pediatric Research · doi:10.1038/s41390-023-02469-6 · Cited by 6
Hu, W., Zhang, X., Wu, Z., Luo, Y., Hu, B., & Zou, X. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s488400 · Cited by 5
“48 Li et al suggested that SOCS3 could serve as a diagnostic and therapeutic target for SAE and hepatic encephalopathy due to its association with immune cells, further supporting our research conclusions.”
Pilipović, I., Stojić-Vukanić, Z., Prijić, I., Jasnic, N. I., Djordjevic, J. D., & Leposavić, G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01246-z · Cited by 5
“2013; Carow and Rottenberg, 2014).”
Lee, Y. J., Park, E. G., Kim, W. R., Bae, W. H., Lee, D. H., Lee, Y., Kim, D.-H., Choi, Y. H., Cha, H., Kim, S., et al. (2022) · Aquaculture · doi:10.1016/j.aquaculture.2022.738811 · Cited by 5
Titanji, B. K., Lee, M., Wang, Z., Chen, J., Hui, Q., Re, V. L., So‐Armah, K., Justice, A. C., Xu, K., Freiberg, M. S., et al. (2022) · Frontiers in Genetics · doi:10.2139/ssrn.4149559 · Cited by 6
Multi-Omic Profiles in Infants at Risk for Food Reactions
Beheshti, R., Stone, S., Chandran, D., & Hicks, S. D. (2022) · Genes · doi:10.3390/genes13112024 · Cited by 5
“Notably, IL-6, a putative inflammatory mediator in atopy, is also a potent activator of the JAK-STAT pathway [29–31], which has been implicated in atopy and airway hyper-reactivity [32,33].”
BackgroundJin, X., Xu, H., Hu, Q., Yin, Y., Qin, M., & Xia, Z. (2023) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02240-2 · Cited by 5
“Among the SOCS protein family, SOCS3 is an important member and a cytokine-induced negative regulator of cytokine signaling pathways (Carow and Rottenberg 2014).”
Sobah, M. L., Liongue, C., & Ward, A. C. (2024) · Journal of Innate Immunity · doi:10.1159/000538364 · Cited by 4
“In addition, germline STAT3 mutations – presumed to be LOF – have been linked to the development of autoimmunity and impaired innate immunity leading to enhanced susceptibility to infection [10, 72].”
BackgroundHe, J., Ganesamoorthy, D., Chang, J. J. ‐., Zhang, J., Trevor, S. L., GIBBONS, K. S., McPherson, S. J., Kling, J. C., Schlapbach, L. J., Blumenthal, A., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11078-z · Cited by 8
“Most genes in the first peak are actively involved in inflammatory processes and immune response, including CD36 [49] , SOCS3 [50] , TNFRSF1A [51] , STAT3 [52] , PTEN [53], and PRKCB [54].”
Wang, G., Xiao, G., Hai, L., Chen, G., Wang, X., Wen, P., Li, T., Wen, J., & Xiao, X. (2017) · Shock · doi:10.1097/shk.0000000000001071 · Cited by 5
Sanati, G., Jafari, D., Noruzinia, M., Daryani, N. E., Ahmadvand, M., Teimourian, S., & Rezaei, N. (2022) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v14i2.8887 · Cited by 5
“The suppressors of cytokine signaling (SOCS) 3 protein as a member of SOCS family is the key physiological regulators of cytokine-mediated activation of STAT3 by inhibiting the catalytic activity of JACKs 11 .”
BackgroundChoudhary, S., Khan, N. S., Verma, R., Saxena, P., Singh, H., Jain, A. K., Thomas, G., Pradhan, D., & Kumar, N. (2023) · 3 Biotech · doi:10.1007/s13205-023-03533-y · Cited by 5
“It’s role in both the disease can be associated to its mechanism of cytokine regulation and inhibiting STAT3 activation which also has a role in cellular pathway (Carow and Rottenberg 2014).”
BackgroundInvolvement of orexin in lipid accumulation in the liver
Mochizuki, A., Nakayama, K., Nakamura, S., Dantsuji, M., Kamijo, R., Shioda, S., Sakurai, T., Ozeki, M., & Inoue, T. (2018) · Journal of Oral Biosciences · doi:10.1016/j.job.2018.07.001 · Cited by 5
Mesaki, K., Yamane, M., Sugimoto, S., Fujisawa, M., Yoshimura, T., Kurosaki, T., Otani, S., Miyoshi, S., Oto, T., Matsukawa, A., et al. (2019) · Surgery Today · doi:10.1007/s00595-018-1753-5 · Cited by 5
Lack of association between SOCS3 and SOCS7 polymorphisms and psoriasis
Özçep, M., Atsü, N., Tekin, N. S., & Çelik, S. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.695 · Cited by 5
“The SOCS family of proteins are cytokine‐inducible inhibitors of the JAK–STAT signaling pathways.(16) Sonkoly et al.”
BackgroundAhmed, C. M. I., Patel, A. P., Johnson, H. M., Ildefonso, C. J., & Lewin, A. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.04.556227 · Cited by 5
“Several studies have shown that SOCS3 inhibits choroidal neovascularization [ 56 –59] and controls infection and inflammation [ 60 , 61 ].”
BackgroundJiang, K., Luan, Y., Shen, N., Qi, X., Hu, L., Wang, Y., Liu, W., Wang, R., Lin, T., & Peng, D. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70538 · Cited by 5
Ulrich, C., Fiedler, R., Herberger, E., Canim, Z., Markau, S., & Girndt, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073719 · Cited by 4
“Other study groups state that SOCS3 lacks affinity to the IL-10 receptor and thus has no effect on IL-10 signaling [36,37].”
BackgroundGaggioli, M. R., Jones, A. G., Panagi, I., Washington, E., Loney, R. E., Muench, J. H., Foster, M. W., Brennan, R. G., Thurston, T. L. M., & Ko, D. C. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115530 · Cited by 5
Cordonier, E. L., Liu, T., Saito, K., Chen, S. S., Xu, Y., & Fukuda, M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00077 · Cited by 4
“Induced SOCS3 inhibits cytokine signaling via the inhibition of JAK activity and targets the receptor complex for proteasomal degradation [4].”
BackgroundÜçal, M., Maurer, C., Etschmaier, V., Hamberger, D., Grünbacher, G., Tögl, L., Roosen, M. J., Molčányi, M., Vorholt, D., Hatay, F. F., et al. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2020.7017 · Cited by 4
“46 Whereas the JAK-STAT pathway is known for the production of inflam-matory cytokines, their inhibition could result in reduction of macrophage IL-10 production given that IL-10 also exerts its anti-inflammatory effects through the same pathway.”
A Review on the Dual Role of SOCS3 in Cancer
Chakraborty, R., Darido, C., Alnakli, A., Hu, H., & Vickery, K. (2022) · Research in Oncology · doi:10.21608/resoncol.2022.114548.1159 · Cited by 4
Nanosphere pharmacodynamics improves safety of immunostimulatory cytokine therapy
Lacinski, R. A., Dziadowicz, S. A., Stewart, A., Chaharbakhshi, E. O., Akhter, H., Pisquiy, J. J., Victory, J. H., Hardham, J. B., Chew, C., Prorock, A. J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108836 · Cited by 4
“Upregulation of SOCS3, an integral regulator responsible for maintaining controlled inflammation downstream of both pro-inflammatory STAT1/STAT3 (IL-6) and STAT4 (IL-12) signal transduction, 71,72 suggests healthy inflammatory signaling with IL12ns dosing.”
IL-17A produced by POMC neurons regulates diet-induced obesity
Gallo, R., Teijeiro, A., Angulo-Aguado, M., & Djouder, N. (2024) · iScience · doi:10.1016/j.isci.2024.110259 · Cited by 4
Gerasimova, T., Poberezhniy, D., Nenasheva, V. V., Stepanenko, E. A., Arsenyeva, E. L., Novosadova, L. V., Grivennikov, I. A., Illarioshkin, S. N., Lagarkova, M. A., Tarantul, V. Z., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179621 · Cited by 4
“Regulates a STAT3-mediated chemokine and chemokine receptor function, causes degradation of p65 NF-κ B [35,36].”
BackgroundHasan, M. U., & Ceyhan, A. (2024) · Tropical Animal Health and Production · doi:10.1007/s11250-024-04147-z · Cited by 4
“Furthermore, the milk characters milk yield, fat, protein, total solids were analyzed to study the effect of SCC on milk yield, fat, protein and total solids.”
Inhibitory DNA Aptamer Tools against SOCS3-gp130 Interactions
Zhang, X., Hou, Y., Chen, W., Fu, T., Wei, Y., & Tan, W. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c09252 · Cited by 4
Crisler, W. J., Rowley, R., Oke, O. H., Steuart, S. J., Modi, M. M., Davis, D. L., Chen, C., Gray, L., Teague, J. E., Zhan, Q., et al. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.05.023 · Cited by 6
Factors regulating Th17 cells: a review
Seki, R., & Nishizawa, K. (2016) · Biomedical Research and Clinical Practice · doi:10.15761/brcp.1000122 · Cited by 4
The role of interleukin-24 in atopic dermatitis
Vu, Y. H., Furue, M., & Tsuji, G. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00002 · Cited by 5
“Suppressor of cytokine signaling-3 (SOCS3) inhibited JAK1, JAK2, and tyrosine protein kinase 2 but not JAK3, and it downregulated STAT3 activation [47].”
BackgroundLi, P., & Luo, L. (2021) · Healthcare · doi:10.3390/healthcare9060618 · Cited by 4
“negative regulator of inflammation by suppressing STAT3 activation [41].”
BackgroundZhu, F. Y., Zhang, D., Shen, F., Xu, K., Huang, X. S., Liu, J., Zhang, J., & Teng, Y. (2021) · IUBMB Life · doi:10.1002/iub.2526 · Cited by 4
Ranganathan, S., Chakraborty, R., Hu, H., Mangani, A. S., Vickery, K., & Ranganathan, S. (2021) · Dental Oral Biology and Craniofacial Research · doi:10.31487/j.dobcr.2021.01.03 · Cited by 4
“This may be because of the lower expression of SOCS3, which has been reported to have a positive feedback loop with STAT3 for Cal 27 [18].”
BackgroundWei, W., Liu, Z., Zhang, C., Khoriaty, R. N., Zhu, M., & Zhang, B. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101536 · Cited by 4
“SOCS3 is a major mediator of inflammation-induced GH resistance in liver (44, 50, 52).”
BackgroundThiazoline-related TRPA1 agonist odorants orchestrate survival fate in micePreprint
Matsuo, T., Isosaka, T., Tang, L., Soga, T., Kobayakawa, R., & Kobayakawa, K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.17.100933 · Cited by 4
“…of Nfkbia and Nfkbiz which suppress NFκb activity, a major protein involved in cytokine production and inflammatory responses (Hayden and Ghosh, 2012), as well as Socs3, which suppresses cytokine signaling (Carow and Rottenberg, 2014), in multiple subpopulations including monocytes and DCs.”
BackgroundA consensus single-cell transcriptomic atlas of dermal fibroblast heterogeneityPreprint
Ascensión, A. M., & Izeta, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.05.611379 · Cited by 4
Individuals with latent tuberculosis in a high TB endemic country show mild COVID-19
Abbas, U., Masood, K. I., Iqbal, T., Jamil, B., Qaiser, S., Yameen, M., Rottenberg, M., Hussain, R., & Hasan, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0339240 · Cited by 3
Self-citationWang, G., Liu, Z., Zheng, Y., Sheng, C., Hou, X., Yao, M., Zong, Q., Tang, D., Zhou, Z., Zhang, T., et al. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073262471231011043339 · Cited by 3
Jeong, H.-N., Lee, T. G., Park, H. J., Yang, Y. D., Oh, S., Kang, S., & Choi, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1328547 · Cited by 3
Marmitt, D. J., Vettorazzi, G., Bortoluzzi, L. D., Alves, C., Silva, J., Pintéus, S., Martins, A., Gaspar, H., Pedrosa, R., da Silva, J., et al. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01547-3 · Cited by 3
“…and inducing STAT3 (Signal Transducer and Activator of Transcription-3)—induces the synthesis of SOCS3 (cytokine-3 signal suppressor), one of the genes responsive to IL-10, which is one important regulator of inflammation (Carow and Rottenberg 2014), blocking the phosphorylation of MAPKs (Fig.”
Elevated Plasma IL-6 Coincides with Activation of STAT3 in PBMC After Acute Resistance Exercise
Tsai, S., Cheng, H.-C., Little, J. P., Islam, H., & Liu, H. (2024) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003503 · Cited by 3
Wenuganen, S., Walton, K. G., Travis, F. T., Tobias Stalder, A., Wallace, R. K., Srivastava, M., & Fagan, J. B. (2025) · Biomolecules · doi:10.3390/biom15030317 · Cited by 3
“SOCS3 plays a major role in regulating inflammation and infections [62,63].”
Thieulent, C., Balasuriya, U. B. R., Tseng, A. E., Crossland, N. A., Stephens, J. M., Dittmar, W., Staszkiewicz, J., Richt, J. A., & Carossino, M. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1513687 · Cited by 4
“Interestingly, both SOCS3 and STAT3 can negatively regulate type I interferon (IFN) responses, with the latter suppressing STAT1 through its sequestration (Ho and Ivashkiv, 2006; Carow and Rottenberg, 2014; Wang et al., 2019).”
Metadata
- Authors
- Carow, B., & Rottenberg, M. E.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Carow, Berit
- ORCID
- Carow, Berit
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 58-58
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC3928676
- OpenAlex
- W2140013858
- Cited by
- 555
- References
- 179
- Citations by year
- 2026: 31 · 2025: 55 · 2024: 65 · 2023: 71 · 2022: 64 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 31 · 2017: 25 · 2016: 27 · 2015: 24 · 2014: 9
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- SOCS3, suppressor of cytokine signaling, infection, inflammation, autoimmune disease, STAT3 activation, JAK kinases, cytokine signaling, receptor ubiquitination, proteasomal degradation, immune homeostasis, myeloid cells, lymphoid cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review